COVID Vaccine Preprint Study Prompts Twitter Outrage

News
890

Translate to Spanish or other 102 languages!

Image for illustration for Illustration purposes.

Medscape

- Advertisement -

A preprint study finding that the Pfizer-BioNTech mRNA COVID vaccine is associated with an increased risk for cardiac adverse events in teenage boys has elicited a firestorm on Twitter. 

Although some people issued thoughtful critiques, others lobbed insults against the authors, and still others accused them of either being anti-vaccine or stoking the fires of the vaccine skeptic movement.

For the complete story, click on the following link: https://www.medscape.com/viewarticle/958778?uac=209076CT&faf=1&sso=true&impID=3641968&src=mkm_covid_update_210915_MSCPEDIT

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
New FDA Records Show Purchases of Fetal Organs, Heads and Tissue for ‘Humanized Mice’ Project
Next article
Grand opening of HEAL Community Connection Center

More Articles

STHS’ Freestanding ERs Earn National Recognition for High-Quality Resuscitation Care

Sudden cardiac arrest is a life-threatening medical emergency that occurs when the heart unexpectedly stops beating, abruptly cutting off blood flow to the brain and other vital organs. It can strike anyone, at any age, often without warning.

New Lancet Commission Outlines Roadmap to Close the Gender Gap in Blood Disorders

A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines practical strategies to improve diagnosis, care and outcomes globally for women and girls with hematological conditions, such as bleeding disorders, heavy menstrual bleeding, postpartum hemorrhage, thrombosis and maternal hematologic complications.

DHR Health Neuroscience Institute Nationally Recognized for Commitment to Excellence in Stroke Care

DHR Health Neuroscience Institute received the American Heart Association’s Get With The Guidelines® - Stroke Gold Plus quality achievement award for its commitment to ensuring people experiencing a stroke receive timely, appropriate treatment based on nationally recognized, research-based guidelines, ultimately helping to save lives and reduce disability.

Accelerator Returns October 15, Expanding Its Focus on Al, Healthcare Access and Community Impact

AltaCair Foundation, in partnership with Genentech as the 2026 co-host, will host its fourth annual Accelerator summit on Thursday, October 15, 2026, from 8:00 a.m. to 12:00 p.m. at the Harlingen Convention Center.
- Advertisement -